“The Right Shot: Vaccine Session I” was held on April 4, 2017 during the 10th International Conference on Typhoid and Other Invasive Salmonelloses, hosted by the Sabin Vaccine Institute’s Coalition against Typhoid. This oral abstract session included:
Moderators
• John Clemens of the International Centre for Diarrhoeal Disease Research, Bangladesh
• Laura Martin, GSK Vaccines Institute for Global Health.
Speakers
• Vinita Vishwanarayan, Clinton Health Access Initiative (1:24)
• Nathan Lo, Stanford University (15:26)
• Akshay Goel, Biological E (32:16)
• Rezwanul Wahid, University of Maryland School of Medicine (48:58)
• Mark Rudolph, University of Maryland School of Medicine (1:04:50)
• Zoe Dyson, University of Melbourne (1:18:57)
The Coalition against Typhoid (CaT), based at the Sabin Vaccine Institute, works to prevent typhoid and other invasive salmonelloses through research, education and advocacy. CaT acts as a catalyst in the global health community to coordinate partnerships, convene decision makers and advocate for sustainable solutions, including access to next-generation vaccines and clean water. For more information, visit [ Ссылка ] and follow us on Twitter, @PreventTyphoid.
The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit with more than two decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit [ Ссылка ] and follow us on Twitter, @SabinVaccine.
